From: Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers
Grade
Negative
n (%)
Positive
Total
Low
3 (50.0%)
6 (100.0%)
Intermediate
9 (60.0%)
6 (40.0%)
15 (100.0%)
High
8 (38.1%)
13 (61.9%)
21 (100.0%)
20 (47.6%)
22 (52.4%)
42 (100.0%)